市場調査レポート
商品コード
1423307
ドライアイ症候群市場レポート:疾患タイプ、薬剤タイプ、製品タイプ、流通チャネル、地域別、2024年~2032年Dry Eye Syndrome Market Report by Disease Type, Drug Type, Product, Distribution Channel, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
ドライアイ症候群市場レポート:疾患タイプ、薬剤タイプ、製品タイプ、流通チャネル、地域別、2024年~2032年 |
出版日: 2024年01月30日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
世界のドライアイ症候群市場規模は2023年に48億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに75億米ドルに達し、2024年から2032年の間に5%の成長率(CAGR)を示すと予測しています。老年人口の増加、様々な年齢層におけるスクリーン使用時間の増加、環境汚染の増加、診断技術の最近の進歩、消費者のヘルスケア支出の増加、大衆の意識の高まり、オンライン小売部門の拡大などが、市場を推進している主な要因の一部です。
ドライアイ症候群とは、目の潤滑と栄養補給のために十分な涙を分泌する能力に影響を及ぼす病状を指します。体が乾燥に対抗しようとするため、充血、炎症、ギトギト感、涙目など、さまざまな症状を引き起こします。ドライアイ症候群は、涙の分泌量や目の表面の質を測定する複数の検査によって診断されます。治療には、市販の人工涙液、処方薬、点鼻プラグなどの外科的治療が行われます。これらの治療法は、不快感を和らげ、視覚の明瞭度を高め、眼全体の健康を改善し、患者の生活の質を高めるのに役立ちます。
最近の診断技術の進歩により、ドライアイ症候群をより正確かつ早期に特定できるようになったことが、市場の成長を促進しています。さらに、目の健康への投資意欲を示す消費者のヘルスケア支出の増加が、もう一つの成長促進要因として作用しています。さらに、大衆の間で意識が高まり、目の健康問題に関する自己診断や専門家による相談が増加していることも、市場成長にプラスの影響を与えています。さらに、眼精疲労やドライアイを助長するライフスタイルの変化を引き起こしている急速な世界化と都市化が、市場成長に好影響を与えています。さらに、オンライン小売セクターの拡大により、OTC治療薬へのアクセスが容易になり、消費者層が広がっていることも、市場成長の起爆剤となっています。これとともに、レーザー手術などの外科的治療が利用しやすくなり、価格も手ごろになっていることも、市場の成長を後押ししています。
老年人口の増加
老人人口の増加は市場成長の重要な促進要因です。ドライアイ症候群は、自然な老化プロセスにより老年人口に多く見られ、涙を十分に分泌する目の能力に影響を与えます。さらに、世界中の国々で平均寿命が延びており、その結果、老人人口が増加しています。この変化は、ドライアイ症候群を含む加齢に関連した病状の有病率に直接的な影響を及ぼしています。その上、老人は慢性的な健康疾患にかかりやすく、これらの疾患で使用される薬には、ドライアイの症状を悪化させる副作用があることが多いです。その結果、ヘルスケアシステムはドライアイ症候群の診断サービスと治療(潤滑点眼薬、処方薬、専門的な眼科医療サービスなど)の両方に対する需要の増加に直面しています。
さまざまな年齢層で増加するスクリーン利用時間
さまざまな年齢層でスクリーン利用時間が増加していることが、ドライアイ症候群市場を刺激する大きな要因となっています。現代のライフスタイルは、スマートフォン、タブレット、コンピューター・モニターなどのデジタル画面にますます依存するようになっています。さらに、リモートワーク文化の台頭により、従業員がデジタル画面に接する機会が増え、まばたきの頻度が低下して目の乾きを引き起こしています。このほか、いくつかの研究では、若年成人におけるスクリーン使用時間の増加とドライアイ症候群の症状との間に強い関連があることが示されています。そのため、デジタル眼精疲労によるドライアイを対象とした治療に対するニーズが高まっており、デジタル眼精疲労を軽減するために設計された市販(OTC)人工涙液、処方箋治療薬、機器に対する消費者の支出が増加しています。
環境汚染の増加
環境要因もドライアイ症候群市場の拡大に重要な役割を果たしています。急速に工業化が進む地域では、汚染された空気や異常気象がドライアイ症候群の症状を悪化させています。これに伴い、大気汚染粒子は炎症を引き起こし、目のデリケートな組織に対してしばしば毒性を示すため、ドライアイの症状を誘発または悪化させています。さらに、清掃用品や塗料、その他の家庭用品から排出される揮発性有機化合物(VOC)を含むさまざまな室内汚染物質は、室内の空気の質を低下させ、目の炎症や乾燥を引き起こします。これに加えて、汚染された環境によるアレルギー反応が、アレルギーに敏感な人のドライアイ症状を誘発することもあります。さらに、環境汚染は気候変動の一因となり、気象パターンや湿度レベルを変化させます。こうした変化は涙の蒸発速度に大きく影響し、特に乾燥地域ではドライアイの症状を悪化させる。
The global dry eye syndrome market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The rising geriatric population, escalating screen time among various age groups, increasing environmental pollution, recent advancements in diagnostic techniques, rising consumer healthcare spending, heightened awareness among the masses, and expansion of the online retail sectors are some of the major factors propelling the market.
Dry eye syndrome refers to a medical condition affecting the eyes' ability to produce adequate tears for lubrication and nourishment. It causes various symptoms, such as redness, irritation, a gritty feeling, and watery eyes as the body tries to counteract the dryness. Dry eye syndrome is diagnosed through multiple tests that measure tear production and eye surface quality. Its treatment involves over-the-counter (OTC) artificial tears, prescription medications, and surgical interventions, such as punctual plugs. These treatments aid in alleviating discomfort, enhancing visual clarity, improving overall eye health, and augmenting patient's quality of life.
The recent advancement in diagnostic techniques, which have enabled more precise and earlier identification of dry eye syndrome, is propelling the market growth. Additionally, the rising consumer healthcare spending, which showcases willingness to invest in eye health, is acting as another growth-inducing factor. Furthermore, the heightened awareness among the masses, leading to an increase in self-diagnosis and professional consultations regarding eye health issues, is positively influencing the market growth. In addition, the rapid globalization and urbanization, which have caused lifestyle changes that are conducive to eye strain and dry eye conditions, are favoring the market growth. Moreover, the expansion of the online retail sector, which provides easier access to OTC treatments, thus broadening the consumer base, is catalyzing the market growth. Along with this, the increasing availability and affordability of surgical treatments, such as laser procedures, is supporting the market growth.
The rising geriatric population
The rising geriatric population is an important driver for the market growth. Dry eye syndrome is more common in the geriatric population due to the natural aging process, which impacts the eye's ability to produce sufficient tears. Furthermore, countries across the globe are experiencing an increase in life expectancy, which, in turn, is increasing the geriatric population. This shift has a direct impact on the prevalence of age-related medical conditions, including dry eye syndrome. Besides this, geriatric adults are more susceptible to chronic health illnesses, and medications used for these conditions often have side effects that exacerbate dry eye symptoms. As a result, healthcare systems are facing an increased demand for both diagnostic services and treatments for dry eye syndrome, such as lubricating eye drops, prescription medications, and specialized eye care services.
The escalating screen time among various age groups
The escalating screen time across various age groups is a substantial factor fueling the dry eye syndrome market. Modern lifestyles are increasingly dependent on digital screens, such as smartphones, tablets, and computer monitors. Furthermore, the emerging remote working culture has extended the exposure of employees to digital screens, which decreases the frequency of blinking, causing dryness in the eyes. Besides this, several studies have indicated a strong association between heightened screen time and symptoms of dry eye syndrome among young adults. Therefore, the escalating need for treatments targeting digital eye strain-induced dry eye is contributing to increased consumer spending on over-the-counter (OTC) artificial tears, prescription treatments, and devices designed to reduce digital eye strain.
The increasing environmental pollution
Environmental factors also play an important role in the expansion of the dry eye syndrome market. Polluted air and extreme weather conditions in rapidly industrializing regions are exacerbating the symptoms of dry eye syndrome. In line with this, air pollution particles cause irritation and are often toxic to the eye's delicate tissues, thus inducing or aggravating dry eye symptoms. Furthermore, various indoor pollutants, including volatile organic compounds (VOCs) emitted from cleaning products, paints, and other household items, reduce indoor air quality and lead to eye irritation and dryness. Besides this, allergic reactions from polluted environments can trigger dry eye symptoms in individuals who are susceptible to allergies. Moreover, environmental pollution contributes to climate change, which can alter weather patterns and humidity levels. These changes significantly affect tear evaporation rates and exacerbate dry eye symptoms, especially in arid regions.
IMARC Group provides an analysis of the key trends in each segment of the global dry eye syndrome market report, along with forecasts at the global and regional levels for 2024-2032. Our report has categorized the market based on disease type, drug type, product, and distribution channel.
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Evaporative dry eye syndrome dominates the market
The report has provided a detailed breakup and analysis of the market based on disease type. This includes evaporative dry eye syndrome and aqueous dry eye syndrome. According to the report, evaporative dry eye syndrome represented the largest segment.
Evaporative dry eye syndrome is dominating the market due to its higher prevalence compared to other types of dry eye syndrome. In this condition, the tear film's lipid layer is compromised, causing faster evaporation of tears, resulting in dryness and irritation. Furthermore, the rising lifestyle-related issues, such as prolonged digital screen usage, exacerbate the symptoms of evaporative dry eye, making it more common among both younger and geriatric populations. Additionally, the recent technological advancements, which have made the diagnosis of evaporative dry eye more straightforward and cost-effective, are contributing to the market growth. Besides this, evaporative dry eye tends to have more chronic and pronounced symptoms, making patients more likely to seek medical interventions and opt for various treatment modalities.
Anti-inflammatory Drugs
Lubricant Eye Drops
Autologous Serum Eye Drops
Anti-inflammatory drugs hold the largest share in the market
A detailed breakup and analysis of the market based on drug type has also been provided in the report. This includes anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. According to the report, anti-inflammatory drugs represented the largest segment.
Anti-inflammatory drugs are dominating the market due to their effectiveness in treating the underlying inflammation associated with dry eye conditions. These drugs act by reducing the inflammation on the eye's surface and tear glands, offering immediate relief and promoting long-term healing. Additionally, they are suitable for treating both aqueous-deficient and evaporative types of dry eye, making them a go-to choice for healthcare providers. Furthermore, anti-inflammatory drugs have a quick onset of action and can be self-administered, making them a preferred choice for those seeking rapid and convenient relief. Besides this, continuous research and development (R&D) in anti-inflammatory medications, leading to the formulation of drugs with fewer side effects and longer-lasting relief, is contributing to the market growth.
Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Others
Liquid drops hold the largest share in the market
A detailed breakup and analysis of the market based on product has also been provided in the report. This includes liquid drops, gel, liquid wipes, eye ointment, and others. According to the report, liquid drops accounted for the largest market share.
Liquid eye drops are dominating the market as they can be quickly and easily administered by patients themselves, providing immediate relief from symptoms. This user-friendly aspect boosts their appeal, especially for people seeking a convenient and fast-acting solution to their eye discomfort. Furthermore, compared to other treatment options such as prescription drugs, surgical interventions, or specialized medical devices, OTC liquid eye drops are generally more affordable, which makes them accessible to a broader population. Additionally, liquid eye drop formulations often include lubricants, electrolytes, and occasionally anti-inflammatory or anti-allergic components that address multiple symptoms at once. Besides this, the small packaging of liquid eye drops allows users to apply them wherever and whenever symptoms arise. This convenience enhances user compliance, making it more likely for patients to adhere to treatment plans.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Hospital pharmacies hold the largest share in the market
A detailed breakup and analysis of the market based on distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies. According to the report, hospital pharmacies accounted for the largest market share.
Hospital pharmacies are dominating the market due to the trust and credibility associated with hospital-based healthcare. Patients often prefer medications and treatments prescribed and dispensed within the same healthcare ecosystem, assuming a higher standard of quality and safety. Besides this, proximity to healthcare professionals provides the ability to fill prescriptions immediately following a consultation or procedure, which is highly appealing to both patients and caregivers. Additionally, hospital pharmacies have a comprehensive inventory of medications, including specialized formulations that might not be readily available at retail or online platforms. Moreover, they have trained healthcare professionals, including pharmacists specialized in ophthalmology, which ensures that patients receive expert advice on medication administration, side effects, and other treatment-related queries.
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
North America exhibits a clear dominance, accounting for the largest dry eye syndrome market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America has an advanced healthcare infrastructure, which ensures easy access to specialized eye care facilities and experienced professionals. Moreover, the high standard of care encourages timely diagnosis and effective treatment, thereby boosting the market growth. Additionally, the increasing healthcare expenditure in the region, which allows individuals to seek professional medical advice and opt for advanced treatment options, is contributing to the market growth. Furthermore, the region is a hub for pharmaceutical innovation and development, which results in the early availability of new treatments and medications. Apart from this, North America has a well-regulated pharmaceutical industry, with stringent guidelines governing the safety and efficacy of medical products, including those for treating dry eye syndrome. Moreover, the escalating geriatric population, which is highly susceptible to dry eye syndrome, is favoring the market growth.
Leading players are heavily investing in creating new formulations, devices, and treatment methods to address different forms of dry eye syndrome more effectively. Furthermore, they are working with research institutions, other pharmaceutical companies, and healthcare providers to accelerate the development of new products and extend their market reach. Besides this, top firms are acquiring smaller companies with innovative technologies to diversify their product portfolio quickly and gain a competitive advantage. Additionally, companies are developing educational campaigns aimed at both healthcare providers and the general public to raise awareness regarding the importance of early diagnosis and effective treatment. Moreover, they are setting up manufacturing units, distribution channels, and partnerships to tap into the growing demand for dry eye treatments in various geographical regions.
Akorn Operating Company LLC
Alimera Science
Allergan plc.
Auven Therapeutics
Bausch + Lomb Incorporated
GlaxoSmithKline plc
Nicox S.A.
Novartis AG
Otsuka Holdings Co., Ltd.
Santen Pharmaceutical Co., Ltd.
In March 2022, Thea, a US-based eye care product company, completed the acquisition of multiple ophthalmic products from Akorn Operating Company LLC.
In September 2021, Bausch + Lomb Incorporated collaborated with Novaliq Gmbh to develop a new drug, NOV03, for the treatment of dry eye disease.
In August 2022, Nicox S.A. announced that it will be working on the development of NCX 4251 as a treatment for dry eye disease.